Icecure Medical Ltd (NASDAQ:ICCM) price on current trading day, rose 6.58% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.05.
A look at the stock’s price movement, the level at last check in today’s session was $0.99, moving within a range at $1.0 and $1.2099. The beta value (5-Year monthly) was 2.506. Turning to its 52-week performance, $1.63 and $0.47 were the 52-week high and 52-week low respectively. Overall, ICCM moved 4.89% over the past month.
Icecure Medical Ltd’s market cap currently stands at around $72.11 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-28.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ICCM is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend ICCM as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ICCM’s current price about 3.11% and 4.61% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 55.63, while 7-day volatility ratio is 3.78% and 6.54% in the 30-day chart. Further, Icecure Medical Ltd (ICCM) has a beta value of 1.40. Analysts have given the company’s stock an average 52-week price target of $4.125, forecast between a low of $2.5 and high of $5.75. Looking at the price targets, the low is -138.1% off recent price level in today’s trading while to achieve the yearly target high, it has to move -447.62%. Nonetheless, investors will most likely welcome a -292.86% jump to $4.125 which is the analysts’ median price.
If we refocus on Icecure Medical Ltd (NASDAQ:ICCM), historical trading data shows that trading volumes averaged 0.4 over the past 10 days and 314.37K over the past 3 months. The company’s latest data on shares outstanding shows there are 58.62 million shares.
The 49.23% of Icecure Medical Ltd’s shares are in the hands of company insiders while institutional holders own 0.21% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.36 million on 2025-07-15, giving us a short ratio of 0.93. The data shows that as of 2025-07-15 short interest in Icecure Medical Ltd (ICCM) stood at 707.00005 of shares outstanding, with shares short rising to 0.21 million registered in 2025-06-13. Current price change has pushed the stock 28.90% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ICCM stock continues to rise going into the next quarter.
